CompaniesCamargo Pharmaceutical Services

Camargo Pharmaceutical Services

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

0

As Collaborator

4

Total Enrollment

344

By Phase

PHASE1: 2PHASE2: 2

By Status

COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
NCT01408602
Hover over trial bars to see details

Recent Trials

NCT04790136Collaborator
Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration
PHASE1Completed
18 participants
Started: Mar 17, 2021 · Completed: May 12, 2021
NCT01408602Collaborator
A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients
PHASE2Unknown
300 participants
Started: Nov 30, 2011 · Completed: Jul 31, 2014
NCT00864110Collaborator
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
PHASE1Completed
4 participants
Started: Apr 30, 2010 · Completed: Dec 31, 2010
NCT00865319Collaborator
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
PHASE2Completed
22 participants
Started: Jun 30, 2009 · Completed: Dec 31, 2010
Related Companies
Premier Research
acquired